NCT02695719View on ClinicalTrials.gov

Lubiprostone for Treatment of Chronic Idiopathic Constipation

PHASE3CompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

April 14, 2016

Primary Completion Date

January 20, 2017

Study Completion Date

February 24, 2017

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG

Placebo

Lubiprostone placebo-matching capsules

DRUG

Lubiprostone

Lubiprostone capsules

Trial Locations (5)

Unknown

Cheonan-si

Seongnam-si

Iksan-si

Daejeon

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY